Nabriva Therapeutics AG CEO Theodore Schroeder's 2019 pay falls 40% to $1.5M
Nabriva Therapeutics AG reports 2019 executive compensation
By ExecPay News
Published: June 25, 2020
Nabriva Therapeutics AG reported fiscal year 2019 executive compensation information on June 25, 2020.
In 2019, three executives at Nabriva Therapeutics AG received on average a compensation package of $1.2M, a 30% decrease compared to previous year.
Average pay of disclosed executives at Nabriva Therapeutics AG
Theodore Schroeder, Chief Executive Officer, received $1.5M in total, which decreased by 40% compared to 2018. 37% of Schroeder's compensation, or $560K, was in salary. Schroeder also received $119K in non-equity incentive plan, $478K in option awards, $310K in stock awards, as well as $28K in other compensation.
Steven Gelone, Chief Operating Officer, received a compensation package of $1.2M, which decreased by 12% compared to previous year. 40% of the compensation package, or $472K, was in salary.
Jennifer Schranz, Chief Medical Officer, earned $982K in 2019.
Related executives
You may also like
Source: SEC filing on June 25, 2020.